REFRACTORY FOCAL EPILEPSY
Clinical trials for REFRACTORY FOCAL EPILEPSY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY FOCAL EPILEPSY trials appear
Sign up with your email to follow new studies for REFRACTORY FOCAL EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough seizures: RAP-219 safety trial opens
Disease control Recruiting nowThis study tests the long-term safety of an experimental drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to current treatments. Participants must have completed a prior RAP-219 study. The main goal is to track side effects, while a…
Matched conditions: REFRACTORY FOCAL EPILEPSY
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Scientists hunt for hidden genetic triggers of severe childhood epilepsy
Knowledge-focused Recruiting nowThis study aims to find genetic mutations in the brain that cause drug-resistant epilepsy in children. Researchers will compare DNA from blood and brain tissue, including samples from special electrodes used during surgery. The goal is to better understand the root causes of thes…
Matched conditions: REFRACTORY FOCAL EPILEPSY
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC